CareFusion Corp. (CFN1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
NATIONAL COMMERCIAL BANKS
CEO:
Kieran T. Gallahue
Employees:
16,000
3750 TORREY VIEW COURT, SAN DIEGO, CA 92130
800-684-8880

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, and respiratory care.

Data derived from most recent annual or quarterly report
Market Cap 12.42 Billion Shares Outstanding207.31 Million Avg 30-day Volume 3.137 Million
P/E Ratio25.0533 Dividend Yield0.0 EPS2.39
Price to Revenue3.0143 Debt to Equity0.3617 EBITDA855 Million
Price to Book Value2.2337 Operating Margin15.903 Enterprise Value12.343 Billion
Current Ratio4.726 EPS Growth0.399 Quick Ratio3.739
1 Yr BETA 0.4717 52-week High/Low 0.0 / Profit Margin12.0314
Operating Cash Flow Growth-9.0352 Altman Z-Score3.2739 Free Cash Flow to Firm 529.16 Million
View SEC Filings from CFN1 instead.

View recent insider trading info

Funds Holding CFN1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CFN1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OHALLERAN MICHAEL D

  • Director
No longer subject to file 2015-03-17 0

MILLER EDWARD D JR

  • Director
No longer subject to file 2015-03-17 0

LOSH J MICHAEL

  • Director
No longer subject to file 2015-03-17 0

KOSECOFF JACQUELINE B

  • Director
No longer subject to file 2015-03-17 0

FRANCIS PHILIP L

  • Director
No longer subject to file 2015-03-17 0

FRIEL ROBERT F

  • Director
No longer subject to file 2015-03-17 0

LUCIER GREGORY T

  • Director
No longer subject to file 2015-03-17 0

GALLAHUE KIERAN CHAIRMAN AND CEO

  • Officer
  • Director
No longer subject to file 2015-03-17 0

STAFSLIEN JOAN EVP, GENERAL COUNSEL

  • Officer
No longer subject to file 2015-03-17 0

LEONARD THOMAS J PRESIDENT, MEDICAL SYSTEMS

  • Officer
No longer subject to file 2015-03-17 0

LA FORTUNE GORDON EVP, EMEA/ANZ COMMERCIAL OPS

  • Officer
No longer subject to file 2015-03-17 0

HINRICHS JAMES F. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2015-03-17 0

ABBEY DONALD EVP, QUALITY REG & MED AFFAIRS

  • Officer
No longer subject to file 2015-03-17 0

BOSE SUPRATIM

  • Director
No longer subject to file 2015-03-17 0

WYGANT JONATHAN SVP, CHIEF ACCOUNTING OFFICER

  • Officer
No longer subject to file 2015-03-17 0

PAOLUCCI MICHAEL E EVP, HUMAN RESOURCES

  • Officer
No longer subject to file 2015-03-17 0

WAYMAN ROBERT PAUL

  • Director
No longer subject to file 2014-11-06 0

MARCHETTI ROGER EVP, HUMAN RESOURCES

  • Officer
12,436 2014-06-09 0

JAIN VIVEK PRES., PROCEDURAL SOLUTIONS

  • Officer
49,765 2013-08-15 0

MASCHAL JEAN SVP, CHIEF ACCOUNTING OFFICER

  • Officer
13,139 2013-05-22 0

LOPEZ ANTHONY SVP AND GM, RESPIRATORY

  • Officer
1,924 2011-08-16 0

SCHLOTTERBECK DAVID L CHAIRMAN AND CEO

  • Officer
  • Director
67,963 2010-12-09 0

WINSTEAD DWIGHT CHIEF OPERATING OFFICER

  • Officer
40,467 2010-12-07 0

COONEY CATHY EVP, HUMAN RESOURCES

  • Officer
11,436 2010-12-07 0

CARDINAL HEALTH INC

  • 10% Owner
No longer subject to file 2010-09-15 0

BORKOWSKI EDWARD CHIEF FINANCIAL OFFICER

  • Officer
29,725 2010-09-15 0

ZILM CAROL PRESIDENT, CRITICAL CARE

  • Officer
0 2009-09-15 0

HARTY LINDA S

  • FORMER DIRECTOR
No longer subject to file 2009-08-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments